Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Rapid Micro Biosystems, Inc. (RPID) had Revenue of $7.84M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$7.84M
Net Income	$-11.51M
Cost of Goods Sold	$7.14M
Gross Profit	$0.70M
Operating Expenses	$19.21M
Operating Income	$-11.37M
Non-Operating Income/Expense	$-0.12M
Pre-Tax Income	$-11.50M
Normalized Pre-Tax Income	$-11.50M
Income after Taxes	$-11.51M
Income from Continuous Operations	$-11.51M
Consolidated Net Income/Loss	$-11.51M
Normalized Income after Taxes	$-11.51M
EBIT	$-11.37M
EBITDA	$-10.57M
Weighted-Average Shares Outstanding (Basic)	44.96M
Weighted-Average Shares Outstanding (Diluted)	44.96M
Earnings per Share (EPS) (Basic)	$-0.26
Earnings per Share (EPS) (Diluted)	$-0.26
Balance Sheet Financials
Current Assets	$69.95M
Property, Plant, and Equipment	$9.58M
Long-Term Assets	$14.46M
Total Assets	$84.41M
Current Liabilities	$16.55M
Long-Term Debt	$18.83M
Long-Term Liabilities	$23.53M
Total Liabilities	$40.08M
Common Equity	$44.33M
Tangible Shareholders Equity	$44.33M
Shareholders Equity	$44.33M
Common Shares Outstanding	44.31M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-27.82M
Cash Flow from Investing Activities	$10.44M
Cash Flow from Financial Activities	$19.33M
Beginning Cash	$17.28M
End Cash	$19.23M
Increase/Decrease in Cash	$1.95M
Stock-Based Compensation	$3.41M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.23
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.30
Debt to Equity Ratio	0.42
Gross Margin	8.88%
Operating Margin	-145.09%
EBIT Margin	-145.09%
EBITDA Margin	--
Pre-Tax Profit Margin	-146.68%
Profit Margin	-146.78%
Free Cash Flow	$-28.57M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.09
Inventory Turnover	0.34
Receiveable Turnover	1.44
Days Sales in Receivables	62.35
Return on Equity	-25.95%
Return on Tangible Equity	-25.95%
Return on Assets	-13.63%
Return on Investments	-18.22%
Book Value Per Share	$1.00
Free Cash Flow per Share	$-0.64
Operating Cash Flow per Share	$-0.62

Data from Zacks Investment Research, Inc.